Serial 97159689
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Sept 2028: the §8 declaration of use).
Record
- Serial number
- 97159689
- Registration number
- 6848542
- Mark type
- Design / logo
- Filed
- 07 Dec 2021
- Published for opposition
- 08 Feb 2022
- Registered
- 13 Sept 2022
- Next maintenance filing
- §8 declaration of use, due by 13 Sept 2028 (grace period to 13 Mar 2029)
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations
Owner
- BIOGEN INTERNATIONAL GMBH, BAAR, CH
- Biogen MA Inc., Cambridge, MA
- Biogen MA Inc., Cambridge, MA
- Biogen MA Inc., Cambridge, MA
Prosecution history
- 30 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2022 — USE AMENDMENT FILED
- 01 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 05 Apr 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Feb 2022 — PUBLISHED FOR OPPOSITION
- 19 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jan 2022 — ASSIGNED TO EXAMINER